Objective: To detect myocardial damage in severe systemic inflammation by c
TnI measurements in patients without acute coronary syndromes.
Design: Prospective case control study.
Setting: Tertiary referral center.
Participants: Twenty patients with sepsis, septic shock, and systemic infla
mmatory response syndrome (SIRS) were examined and compared to controls wit
hout coronary artery disease or myocarditis.
Measurements and results: cTnI levels were assessed in patients with SIRS,
sepsis, and septic shock. Eight patients (two female/six male) suffered fro
m septic shock, nine (three female/six male) from sepsis without shock, and
three (three male) from SIRS. Seventeen patients (85 %) showed elevated cT
nI (median 0.57 mug/l; 0.17-15.4), whereas no patient in the control group
showed elevated cTnI (P < 0.0001). Six patients (30 %), - three with septic
shock and three with sepsis - died during hospitalization, five of them wi
th elevated cTnI. Four out of five autopsies showed normal coronary arterie
s. Coronary angiography, autopsy, and stress echocardiography ruled out sig
nificant coronary artery disease in ten cTnI-positive patients (59 %). In 4
1 % of cTnI-positive patients, Streptococcus pneumoniae could be cultured,
whereas no cTnI-negative or control patient showed signs of infection due t
o S. pneumoniae.
Conclusion: Cardiac troponin I was elevated in 85 % of patients with sepsis
, septic shock or SIPS in our study. A high percentage showed infection cau
sed by S. pneumoniae. In what way microorganisms cause cTnI elevations is n
ot yet understood.